What is IMSI?
Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) is an advanced fertility technique designed to improve the chances of successful fertilization, especially in cases
of male infertility. Unlike conventional IVF, where sperm is selected under 400x magnification, IMSI uses a high-powered microscope to magnify sperm up to 6,000x. This allows
embryologists to assess the sperm in great detail, selecting those with the best morphology for injection into the egg. The goal is to enhance the chances of producing a healthy
embryo by eliminating sperm with visible abnormalities.
IMSI offers significant advantages for couples facing male infertility or recurrent IVF failures. By selecting only the healthiest sperm, the technique improves the chances of
fertilization, reduces the risk of miscarriage, and enhances embryo quality. At MOM IVF, we utilize IMSI as part of our commitment to delivering the most advanced, individualized
fertility solutions, providing hope and success for couples on their journey to parenthood.
Who Can Benefit from IMSI?
- Couples where the male partner has poor sperm quality.
- Individuals with abnormal sperm morphology.
- Men with high levels of DNA fragmentation in their sperm.
- Couples who have experienced repeated IVF failures.
- Those with a history of recurrent miscarriages due to sperm-related issues.
What is Donor IVF?
Donor IVF is a specialized fertility treatment where a donor's eggs or sperm are used to achieve successful fertilization. This option is ideal for individuals or couples who are
unable to conceive using their own eggs or sperm due to medical conditions, genetic concerns, or advanced reproductive age. In Donor IVF, the selected donor's eggs or sperm are combined
with the partner's through in vitro fertilization, and the resulting embryo is then transferred to the recipient's uterus.
Donor IVF significantly increases the chances of conception, especially for those who have had multiple failed IVF attempts. By using healthy donor eggs or sperm, the success rate of
fertilization and pregnancy is higher. At MOM IVF, we carefully screen all donors and ensure they meet the highest standards to provide the best outcomes for our patients. With
personalized care and advanced technology, we help individuals and couples achieve their dream of parenthood.
Who Can Benefit from Donor IVF?
- Women with diminished ovarian reserves or poor egg quality.
- Individuals who have undergone premature menopause.
- Those with genetic conditions affecting their eggs or sperm.
- Men with severe sperm abnormalities or infertility due to genetic factors.
- Couples who have experienced repeated IVF failures due to egg or sperm issues.
- Same-sex couples or single individuals wishing to start a family.
What is Genetic Testing?
Genetic Testing in the context of fertility is a sophisticated process that allows doctors to screen embryos for genetic abnormalities before implantation. The two main types of
genetic testing used in IVF are Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Preimplantation Genetic Testing for Monogenic/Single Gene Disorders (PGT-M). PGT-A checks
for chromosomal abnormalities, such as Down syndrome, while PGT-M screens for specific inherited genetic conditions like cystic fibrosis or sickle cell disease. These tests are
performed on embryos created through IVF to help select the healthiest, genetically sound embryos for transfer.
Genetic testing enhances the success rate of IVF by reducing the risk of miscarriage and increasing the chances of a healthy pregnancy. By identifying embryos with the correct number
of chromosomes or those free from genetic conditions, couples can make informed decisions and improve their odds of successful implantation. At MOM IVF, we prioritize the health of
both the parents and the future child, offering state-of-the-art genetic screening to give families peace of mind and better outcomes on their fertility journey.
Who Can Benefit from Genetic Testing?
- Couples with a family history of genetic disorders.
- Women over the age of 35, where the risk of chromosomal abnormalities is higher.
- Couples who have experienced recurrent miscarriages.
- Individuals with multiple failed IVF cycles due to suspected genetic issues.
- Couples using donor eggs or sperm who want to ensure the health of the embryos.
- Those with known single-gene disorders, such as cystic fibrosis or sickle cell disease, seeking to avoid passing them on to their child.